loadpatents
Patent applications and USPTO patent grants for Nair; Anilkumar.The latest application filed is for "antidiabetic bicyclic compounds".
Patent | Date |
---|---|
Antidiabetic bicyclic compounds Grant 10,968,193 - Chen , et al. April 6, 2 | 2021-04-06 |
Antidiabetic tricyclic compounds Grant 9,932,311 - Biftu , et al. April 3, 2 | 2018-04-03 |
Antidiabetic Bicyclic Compounds App 20170217918 - Chen; Helen ;   et al. | 2017-08-03 |
Antidiabetic Tricyclic Compounds App 20160207887 - Biftu; Tesfaye ;   et al. | 2016-07-21 |
Spirolactam CGRP receptor antagonists Grant 9,296,750 - Bell , et al. March 29, 2 | 2016-03-29 |
Pyridine CGRP receptor antagonists Grant 9,227,973 - Bell , et al. January 5, 2 | 2016-01-05 |
Aliphatic spirolactam CGRP receptor antagonists Grant 9,227,972 - Bell , et al. January 5, 2 | 2016-01-05 |
Aliphatic Spirolactam Cgrp Receptor Antagonists App 20150203496 - Bell; Ian M. ;   et al. | 2015-07-23 |
Spirolactam Cgrp Receptor Antagonists App 20150111914 - Bell; Ian M. ;   et al. | 2015-04-23 |
Pyridine Cgrp Receptor Antagonists App 20150099771 - Bell; Ian M. ;   et al. | 2015-04-09 |
Heterocyclic Cgrp Receptor Antagonists App 20150087641 - Bell; Ian M. ;   et al. | 2015-03-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.